Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339987 · ClinicalTrials.gov registry record
Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration
A clinical trial, sponsored by Saint John's Cancer Institute.
- Terminated
- Registry status
- 27
- Enrollment target
NCT02339987: Clinical Trial study, sponsored by Saint John's Cancer Institute.
NCT02339987 is a clinical trial that was terminated before completion, run by Saint John's Cancer Institute. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02339987 was terminated before completion, sponsored by Saint John's Cancer Institute.
- TERMINATED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)
Primary Outcome
Cell viability, viable number and TIL potency using standardized methods
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2014-11 |
| Est. Completion | 2018-06-04 |
Why NCT02339987 stopped before completion
NCT02339987 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02339987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02339987 about?
NCT02339987 is a clinical study titled "Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration". Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration Lymphocytes (TIL)
What is the current status of trial NCT02339987?
This trial is currently terminated. The enrollment target is 27 participants. The study started on 2014-11. Estimated completion is 2018-06-04.
Who is sponsoring clinical trial NCT02339987?
This trial is sponsored by Saint John's Cancer Institute, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia